---
title: "LIVZON PHARMA's application for marketing authorization of Lecanemab injection has been accepted"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/270913593.md"
description: "LIVZON PHARMA announced that its holding subsidiary, LIVZON Monoclonal Antibody, received a notification from the National Medical Products Administration. The application for the domestic production drug registration and marketing authorization of the monoclonal antibody injection, jointly developed with Beijing Xinkanghe, has been accepted. The intended indication is for adult patients with moderate to severe plaque psoriasis suitable for systemic therapy or phototherapy"
datetime: "2025-12-28T09:56:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/270913593.md)
  - [en](https://longbridge.com/en/news/270913593.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/270913593.md)
---

# LIVZON PHARMA's application for marketing authorization of Lecanemab injection has been accepted

LIVZON PHARMA (01513.HK) announced that its holding subsidiary, LIVZON Monoclonal Antibody, received a notification from the National Medical Products Administration. The application for the domestic production drug registration and marketing authorization of Lakanqita Monoclonal Antibody Injection, jointly developed with Beijing Xinkanghe, has been accepted. The intended indication is for adult patients with moderate to severe plaque psoriasis suitable for systemic therapy or phototherapy

### Related Stocks

- [000513.CN](https://longbridge.com/en/quote/000513.CN.md)
- [01513.HK](https://longbridge.com/en/quote/01513.HK.md)

## Related News & Research

- [Livzon Pharmaceutical’s First-Quarter Profit Slips as Policy Shift and Seasonality Hit Revenue](https://longbridge.com/en/news/283852429.md)
- [Kickstarter just killed its new mature content rules](https://longbridge.com/en/news/286954763.md)
- [Grown Up Group Sets June 2026 AGM to Approve Results and Share Mandate](https://longbridge.com/en/news/286990715.md)
- [09:15 ETNewport Healthcare's 2025 Outcomes Report Demonstrates Significant Improvements in Teen and Young Adult Mental Health Following Treatment](https://longbridge.com/en/news/286920260.md)
- [CertifID Launches New Client Experience to Simplify Real Estate Transactions](https://longbridge.com/en/news/286944337.md)